» Authors » Saarraaken Kulenthiran

Saarraaken Kulenthiran

Explore the profile of Saarraaken Kulenthiran including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 21
Citations 142
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
11.
Egger F, Blumenauer D, Fischer P, Venhorst A, Kulenthiran S, Bewarder Y, et al.
Clin Res Cardiol . 2021 Jun; 111(3):264-271. PMID: 34091726
Background: During the COVID-19 pandemic, compulsory masks became an integral part of outdoor sports such as jogging in crowded areas (e.g. city parks) as well as indoor sports in gyms...
12.
Al Ghorani H, Kulenthiran S, Lauder L, Bohm M, Mahfoud F
J Hum Hypertens . 2021 Jan; 35(5):398-409. PMID: 33437020
Hypertension is one of the most prevalent cardiovascular diseases and its treatment requires multimodal therapeutic approaches. This review aims to provide a summary and update on relevant evidence in hypertension...
13.
Mahfoud F, Kulenthiran S
EuroIntervention . 2020 May; 16(1):21-23. PMID: 32439627
No abstract available.
14.
Mahfoud F, Ewen S, Kulenthiran S
JACC Cardiovasc Interv . 2020 May; 13(10):1248-1250. PMID: 32438997
No abstract available.
15.
Kulenthiran S, Emrich I, Bewarder Y, Hubner W, Mahfoud F, Bohm M, et al.
Herz . 2020 Apr; 45(3):301-310. PMID: 32322936
A careful and standardized but nevertheless individually adapted and targeted medical history and physical examination are essential components of a preoperative evaluation. The individual cardiovascular risk profile characterized by noninvasive...
16.
Scholz S, Lauder L, Ewen S, Kulenthiran S, Marx N, Sakhov O, et al.
Clin Res Cardiol . 2020 Feb; 109(7):857. PMID: 32100094
The original version of this article unfortunately contained a mistake. The given name and family name of the fourth author Saaraaken Kulenthiran were switched in the original publication.
17.
Scholz S, Lauder L, Ewen S, Kulenthiran S, Marx N, Sakhov O, et al.
Clin Res Cardiol . 2019 Dec; 109(7):845-856. PMID: 31792571
Background: Chronic kidney disease (CKD) is highly prevalent in patients with coronary artery disease (CAD). Objective: The outcome following revascularization using contemporary technologies (new-generation abluminal sirolimus-eluting stents with thin struts)...
18.
Lauder L, Ewen S, Tzafriri A, Edelman E, Cremers B, Kulenthiran S, et al.
Cardiovasc Revasc Med . 2018 Mar; 19(7 Pt B):845-851. PMID: 29555535
Background/purpose: Catheter-based renal sympathetic denervation (RDN) has been introduced to lower blood pressure (BP) and sympathetic activity in patients with uncontrolled hypertension with at best equivocal results. It has been...
19.
Stoiber L, Mahfoud F, Mahsa Zamani S, Lapinskas T, Bohm M, Ewen S, et al.
Clin Res Cardiol . 2018 Mar; 107(8):642-652. PMID: 29520698
Renal sympathetic denervation (RDN) is under investigation as a treatment option in patients with resistant hypertension (RH). Determinants of arterial compliance may, however, help to predict the BP response to...
20.
Mahfoud F, Pipenhagen C, Moon L, Ewen S, Kulenthiran S, Fish J, et al.
Int J Cardiol . 2017 May; 241:373-378. PMID: 28465113
Objectives: Anatomic placement of lesions may impact efficacy of radio-frequency (RF) catheter renal denervation (RDN). However, it is unclear if it is necessary to perform treatments post bifurcation with systems...